A global provider of enterprise software solutions for life science and other regulated companies, MasterControl, has revealed it will be highlighting the benefits of advanced quality management systems (QMS) for pharmaceutical companies at Interphex 2017 in New York, USA.
“The FDA explicitly states that the overarching direction of the pharmaceutical current good practice (CGxP) requirements is this: ‘Quality should be built into the product, and testing alone cannot be relied to ensure product quality’,” stated Patricia Santos-Serrao, RAC, director of clinical and regulatory solutions at MasterControl. “An optimised quality management system implemented throughout the entire pharmaceutical product lifecycle is the foundation for long-term regulatory compliance, and ultimately, for ensuring market success.”
While exhibiting the company will provide insights into how best to meet regulatory demands while also reducing costs and time to market.